Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's next-gen obesity drug Cagrisema
Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value.
Obesity drug sales help Novo Nordisk beat expectations
Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations.
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
Novo Nordisk’s multibillion-dollar honeymoon phase spearheaded by Ozempic and Wegovy is ending. Now the Danish drugmaker is hunting for new patients to maintain its crown as Europe’s most valuable company.
CNN on MSN
11d
A new definition of obesity goes beyond BMI. What this could mean for you
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...
Rolling Out
5d
Shocking health risks linked to obesity revealed
Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...
fingerlakes1
20h
Obesity Crisis in the Finger Lakes: Health, Economic, and Social Impacts
The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...
FierceBiotech
3h
Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects
Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. | Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. Months after sharing obesity data that ...
2d
Drinking. Gambling. Online shopping. Researchers are exploring if obesity drugs could curb cravings beyond food.
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
4d
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
4d
on MSN
About half of Americans approve of using weight-loss drugs to treat obesity, new poll finds
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
7d
Report: Obesity, diabetes, high blood pressure remain on the rise in U.S.
Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...
23h
on MSN
Novartis Sets High Bar in Pursuit of Obesity Deals, CEO Says
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novo Nordisk
CagriSema
Feedback